SCHOTT Pharma AG & Co. KGaA (1SXP.DE) Stock

Healthcare · Medical Instruments & Supplies · Member of SDAX

SCHOTT Pharma AG & Co. KGaA (1SXP.DE) closed at EUR 24.50 on 2026-10-14, a change of +26.1 % over the past year, with a market capitalization of EUR 3.7B.

SCHOTT Pharma AG & Co. KGaA recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

SCHOTT Pharma AG & Co. KGaA key figures

Previous close

EUR 24.50 (2026-10-14)

1-year change

+26.1 %

Market cap

EUR 3.7B

Enterprise value

EUR 3.95B

P/E ratio (trailing)

29.23

P/E ratio (forward)

22.42

EPS (trailing)

0.84

EPS (forward)

1.10

PEG ratio

n/a

Price to book

3.68

Revenue growth

10 %

Earnings growth

-13.3 %

Dividend per share (trailing)

0.18

Short ratio

n/a

Employees

5,002

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for SCHOTT Pharma AG & Co. KGaA and compare it with other stocks.